Telehealth ADHD diagnosis and medication in 30 minutes. Done Health rode the pandemic telehealth boom to prescribe Adderall and other controlled stimulants to patients through video calls. They called it access. Critics called it a pill mill. The DEA investigated. The company faced lawsuits. The co-founder was charged with fraud. Done is the cautionary tale of what happens when "move fast and break things" meets controlled substance prescriptions. The poster child for telehealth gone wrong.
Founded
2020
HQ
San Francisco, USA
Total Raised
$43 million
Founder
Ruthia He
Status
Private (under regulatory scrutiny)
Website
www.donefirst.comTHE ORIGIN STORY
Ruthia He founded Done Health in 2020 during the COVID pandemic, when the DEA temporarily relaxed rules around prescribing controlled substances via telehealth. The timing was perfect — millions of people suddenly wanted ADHD diagnoses and medication, and Done offered 30-minute video appointments with clinicians who could diagnose and prescribe stimulants like Adderall.
The company grew explosively. At its peak, Done had thousands of patients and hundreds of clinicians on the platform.
WHAT THEY ACTUALLY DO
Subscription telehealth. Patients pay a monthly subscription fee ($199-$299/month) for ongoing ADHD care — initial evaluation, medication management, and follow-up appointments.
Done connects patients with licensed clinicians via video calls. The company earns from subscription fees.
Prescriptions are filled through partner pharmacies.
THE PRODUCTS
ADHD Evaluation — 30-minute video assessment with a clinician. Medication Management — ongoing prescription management for ADHD stimulants.
Follow-up Care — regular check-ins and dosage adjustments.
HOW THEY GREW
Pandemic telehealth deregulation. COVID prompted the DEA to allow controlled substance prescriptions via telehealth without an in-person visit.
Done rode this regulatory window aggressively, marketing ADHD diagnosis and medication through social media ads targeting people who suspected they had ADHD.
THE HARD PART
Everything. The DEA launched an investigation into Done's prescribing practices.
The company was accused of operating as a "pill mill" — prescribing controlled stimulants too easily to patients who may not have needed them. Co-founder Ruthia He was charged with fraud in 2024.
CVS and Walmart stopped filling Done prescriptions. The company represents the worst-case scenario for telehealth startups prescribing controlled substances.
MONEY TRAIL
Series A
2021 · Led by Various
$20M raised
Series B
2022 · Led by Various
$23M raised
WHO BACKED THEM
Backed by private investors. The company raised $43 million before the regulatory problems emerged.
Specific investor names have been less public given the legal issues.
Related Profiles
Head-to-Head
Compare Done Health vs another company.